GLP-1 receptor agonists exhibit potent antioxidant effects in sepsis by enhancing the expression and activity of key enzymes, such as superoxide dismutase (SOD), glutathione peroxidase (GPx), and catalase, which effectively neutralize ROS that are major mediators of cellular injury during sepsis. This evidence concerns the gene SOD1 and Sepsis.